Agilon Health, Inc. Soars to New 52-Week High of $109.48

Agilon Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 109.48 on June 10, 2026. This achievement underscores the company's remarkable performance over the past year, with a staggering increase of 1417.91%, significantly outpacing the S&P 500's growth of 20.34% during the same period. As a small-cap player in the Pharmaceuticals & Biotechnology industry, Agilon Health, Inc. has garnered attention for its impressive stock performance. The company's market capitalization stands at USD 164 million, reflecting its position within the small-cap segment. Despite being loss-making, the stock's price-to-book ratio is 1.30, indicating a valuation that may attract interest from market participants. The stock's journey from a 52-week low of USD 0.30 to its current high illustrates a remarkable turnaround, highlighting the underlying trends and developments within the company. As Agilon Health, Inc. continues to navigate the competitive landscape of the pharmaceuticals and biotechnology sector, its recent performance marks a noteworthy chapter in its financial narrative.